Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 7981257

Developing a paper for conference presentations.

M M Gregg·L L Pierce
View original source ↗Export metadata ↓

Abstract

Opportunities to expand the professional nursing role and present at conferences have increased. The purpose of this article is to share suggestions for developing and presenting papers. Essential ideas on who will present and how to write an abstract, deal with rejection or success, develop an outline, construct a lecture, select audiovisual materials, and use public speaking skills are described. The publishing and copyright processes are also discussed. Using these practical strategies will enable individuals to develop and/or enhance presentations.

Explore related subjects

Congresses as TopicHumansPublishingSocieties, NursingWritingJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M M Gregg, L L Pierce. 1994. Developing a paper for conference presentations.. https://doi.org/10.1097/00001610-199408000-00003

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

On-demand therapy for gastroesophageal reflux disease.

The following pages summarize the proceedings of a symposium held in May 2006 on the emerging role of on-demand therapy for gastroesophageal reflux disease (GERD). Medical therapy for GERD has undergone significant change in recent years with the advent of effective, but expensive, antisecretory agents. On-demand (patient-driven) therapy is attractive to payers and patients, because it appears to be both cost-effective and convenient. Many individuals appear to accept occasional symptomatic breakthrough in exchange for personal control of their disease. On-demand therapy should be distinguished from intermittent therapy, which is either patient- or physician-driven, but which requires intermittent episodes of continuous therapy followed by discontinuation until symptoms recur. Proton pump inhibitors appear to be effective on-demand agents despite theoretical pharmacodynamic limitations for this class of drug. The available data support the use of on-demand therapy for GERD in uninvestigated reflux disease, nonerosive reflux disease, and possibly mild esophagitis as well. On-demand therapy should not be considered for patients with severe esophagitis.

Congresses as Topic↗